|
|
 |
|
|
LONG GENT at 16.28 See details on: Yahoo, Google, Reuter
by zipjet, 20/11/2006 19:05.
United States
GENT has a single drug in development, defibrotide, but it is going to be successful for this small biotech. The drug has been granted orphan status in the US and EU. ASH in December will present favorable science on the drug. Approval should come in 2008. Stock could be a 3X to 6X by 2009.
--------------------- An Investor With A History Of Lots Of Mistakes. |
| Quick Signup to reply Reply Subscribe A click to moderator |
|
|
| We have 0 replies for this subject (10 replies per page). You are on page #1 |
|
|
 |